Atlas Trials

MEtformin and Lorcaserin for WeighT Loss in Schizophrenia

Clinical trial NCT02796144 · TERMINATED

Trial details

NCT number
NCT02796144
Sponsor
University of North Carolina, Chapel Hill
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
SchizophreniaSchizoaffective DisorderOverweight
Start date
2016-09-01
Primary completion
2020-02-14
Enrollment
71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.